LLY
NYSEELI LILLY & Co
Health Care, Pharmaceuticals
$1,185.71
close 7 Aug 2026
+86.66%
52-week change
$1.12T
market cap
$625.90
$1,249.45
52-week range
| Line item | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||||
| Revenue | $79.67B | $65.18B | $45.04B | $34.12B | $28.54B | $28.32B | $24.54B | $22.32B | $21.49B | $19.97B | $18.31B | $19.96B | $19.62B | $23.11B | $22.60B | $24.29B | $23.08B | $21.84B | $20.37B | $18.63B |
| Cost of revenue | $13.22B | $11.05B | $8.42B | $7.08B | $6.63B | $7.31B | $5.48B | $4.72B | $4.68B | $4.45B | $4.16B | $5.04B | $4.93B | $4.91B | $4.80B | $5.07B | $4.37B | $4.25B | $4.38B | $4.25B |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $14.60B | $13.34B | $10.99B | $9.31B | $7.19B | $6.93B | $5.98B | $5.60B | $5.05B | $5.10B | $5.04B | $4.80B | $4.73B | $5.53B | $5.28B | $5.02B | $4.88B | $4.33B | $3.84B | $3.49B |
| SG&A | $12.24B | $11.09B | $8.59B | $7.40B | $6.44B | $6.43B | $6.12B | $6.21B | $5.98B | $5.98B | $5.84B | $6.53B | $6.62B | $7.13B | $7.51B | $7.88B | $7.05B | $6.89B | $6.63B | $6.10B |
| Operating income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Interest expense | — | $895.00M | $781.00M | $486.00M | $331.60M | $339.80M | $359.60M | $400.60M | $242.50M | $225.00M | $185.20M | $161.20M | $148.80M | $160.10M | $177.80M | $186.00M | $185.50M | $261.30M | -$228.30M | — |
| Tax expense | $6.88B | $5.09B | $2.09B | $1.31B | $561.60M | $573.80M | $1.04B | $628.00M | $529.50M | $2.39B | $551.40M | $381.60M | $609.80M | $1.20B | $1.32B | $1.00B | $1.46B | $1.03B | $764.30M | $923.80M |
| Net income | $26.71B | $20.64B | $10.59B | $5.24B | $6.24B | $5.58B | $6.19B | $8.32B | $3.23B | -$204.10M | $2.74B | $2.41B | $2.39B | $4.68B | $4.09B | $4.35B | $5.07B | $4.33B | -$2.07B | $2.95B |
| Diluted EPS | $29.80 | $22.95 | $11.71 | $5.80 | $6.90 | $6.12 | $6.79 | $8.89 | $3.13 | -$0.1900 | $2.58 | $2.26 | $2.23 | $4.32 | $3.66 | $3.90 | $4.58 | $3.94 | -$1.89 | — |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net margin | 33.53% | 31.67% | 23.51% | 15.36% | 21.88% | 19.71% | 25.24% | 37.27% | 15.04% | -1.02% | 14.95% | 12.07% | 12.19% | 20.27% | 18.09% | 17.90% | 21.97% | 19.82% | -10.17% | 15.85% |
filed 5 Aug 2026